Setting the Standard for NAD+ Restoration in Regulated Markets
CellVive NMN™ (β-Nicotinamide Mononucleotide) is an Active Pharmaceutical Ingredient (API) exclusive to Longevity Life Sciences. CellVive NMN™ is the direct precursor to NAD⁺, which supports energy production, DNA repair, and healthy cellular function. Backed by multiple peer-reviewed human trials, NMN has been shown to elevate NAD⁺levels by three to five times within eight weeks. CellVive NMN™ is produced using proprietary enzymatic synthesis to achieve ≥99% purity and manufactured to pharmaceutical standards.
CellVive NMN™ is now a permitted ingredient for use in Listed medicines (AUST L) under the Australian Register of Therapeutic Goods (ARTG)
Australia’s only Approved and Validated Nicotinamide Mononucleotide (NMN) for Listed Medicines
Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and related to vitamin B₃. It plays a key role as a direct precursor to NAD⁺ (Nicotinamide Adenine Dinucleotide), which is an essential coenzyme involved in energy metabolism and many cellular functions. Science has demonstrated that NAD⁺ levels naturally decline with age, causing age related diseases. NMN has become a focus of scientific research for its role in supporting this vital pathway.
Pharmaceutical-Standard Purity and Process
CellVive NMN™ delivers ≥99% purity through pharmaceutical-standard manufacturing, ensuring unmatched consistency, stability, and quality assurance.
Backed by over 15 clinical trials and Australian university partnerships, NMN delivers proven NAD⁺ elevation and evidence-based benefits for energy, repair, and cellular resilience.
Available solely through Longevity Life Sciences, CellVive NMN™ combines guaranteed supply assurance with collaborative scientific and regulatory support.
Cellvive NMN™ is produced to the same stringent standards as pharmaceutical ingredients, offering the scientific credibility and compliance today’s longevity market demands.
Our Dedicated Raw-Material Manufacturing Facility
SyncoZymes’ state-of-the-art green-manufacturing facility underpins our global leadership in NMN innovation. Based in Zhangjiang High-Tech Park, the GMP-certified site employs advanced biocatalysis and enzyme-technology platforms to deliver high-purity co-enzymes and health-industry intermediates. Committed to sustainability, SyncoZymes deploys green-chemical processes, low-impact waste management and energy-efficient production systems. As LLS’s exclusive manufacturing partner, this facility enables us to deliver world-class CellVive NMN™ to US, Asia pacific, UK, Europe and South Africa at regulatory-grade standards at scale
